Patient Guide: A Study to Learn How Safe the Study Treatment Actinium-225-macropa-pelgifatamab (BAY3546828) is, How it Affects the Body, How it Moves Into, Through and Out of the Body, and About Its Anticancer Activity in Participants With Advanced Metastatic Castration-resistant Prostate Cancer (mCRPC)

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 31 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT06052306
Status: ACTIVE_NOT_RECRUITING
Condition: Metastatic Castration-resistant Prostate Cancer
Phase: PHASE1

Find a Study Location Near You

This study is available at 31 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Duarte, California
  • Minneapolis, Minnesota
  • Omaha, Nebraska
  • • And 28 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily